✦ LIBER ✦

A pilot study of neoadjuvant chemotherapy with 5-fluorouracil and cisplatin with surgical resection and postoperative radiation therapy and/or chemotherapy in adenocarcinoma of the esophagus

✍ Scribed by Robert W. Carey; Cheryl Bromberg; Alan D. Hilgenberg; Douglas J. Mathisen; Hermes C. Grillo; John C. Wain; Diana L. Logan; Noah C. Choi

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 404 KB
Volume: 68
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19910801)68:3<489::aid-cncr2820680307>3.0.co;2-m

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined treatment of invasive bladder c

Combined treatment of invasive bladder carcinoma with transurethral resection, induction chemotherapy, and radical radiotherapy plus concomitant protracted infusion of cisplatin and 5-fluorouracil : A Phase I Study

✍ Donatella Tirindelli Danesi; Giorgio Arcangeli; Enrico Cruciani; Antonella Mecoz 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 1 views

## BACKGROUND. The aim of this study was to define the maximum tolerated doses

Role of salvage chemotherapy with topote

Role of salvage chemotherapy with topotecan and cisplatin in patients with paclitaxel- and platinum-resistant recurrent ovarian or primary peritoneal cancer: A phase II pilot study

✍ Ghamande, Sharad A.; Piver, M. Steven 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 1 views

## Background and Objectives: We assessed the role of salvage chemotherapy with topotecan and cisplatin in patients with platinum-and paclitaxel-resistant advanced and recurrent ovarian or primary peritoneal cancer, based on the reported in vivo and in vitro synergism between these two drugs. Meth

High rate of clinical complete response

High rate of clinical complete response to weekly outpatient neoadjuvant chemotherapy in oral carcinoma patients using a new regimen of cisplatin, 5-fluorouracil, and bleomycin alternating with methotrexate and epirubicin

✍ Jin-Ching Lin; Jian-Sheng Jan; Chen-Yi Hsu; Daniel Yong-Kie Wong 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 1 views

A Phase II trial was initiated to evaluate the response to and toxicity of a new regimen of weekly outpatient neoadjuvant chemotherapy in patients with oral carcinoma. ## METHODS. Patients with previously untreated squamous cell carcinoma of the oral cavity were eligible for this trial. The neoad

A Phase I/II study of external beam radi

A Phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207) : Final report

✍ Laurie E. Gaspar; Kathryn Winter; Walter I. Kocha; Lawrence R. Coia; Arnold Hers 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

## Background: A multiinstitutional, prospective study of the radiation therapy oncology group (rtog) was designed to determine the feasibility and toxicity of chemotherapy, external beam radiation, and esophageal brachytherapy (eb) in a potentially curable group of patients with adenocarcinoma or

Hyperfractionated radiation therapy and

Hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and mitomycin-C (± granulocyte-colony stimulating factor) in the treatment of patients with locally advanced head and neck carcinoma

✍ André A. Abitbol; Kasi S. Sridhar; Alan A. Lewin; James G. Schwade; William Raub 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 1 views

initial entry of 34 patients. Cancer Center, University of Miami School of RESULTS. At a median follow-up of 41 months (range, 12-80 months), 44 patients Medicine, Miami, Florida. were alive with a projected median overall survival of 54 months. Grade 3/4 muco-2 Regional Cancer Center, Baptist Hosp